Cover Image

Programmatic factors associated with the limited impact of Community-Directed Treatment with Ivermectin to control Onchocerciasis in three drainage basins of South West Cameroon.

The CDTI model is known to have enhanced community participation in planning and resource mobilization toward the control of onchocerciasis. These effects were expected to translate into better individual acceptance of the intervention and hence high Treatment Coverage, leading to a sustainable comm...

Full description

Saved in:

Bibliographic Details
Main Authors:	Christian Tetteh Duamor (Author), Fabrice Roberto Datchoua-Poutcheu (Author), Winston Patrick Chounna Ndongmo (Author), Aldof Tah Yoah (Author), Ernest Njukang (Author), Emmanuel Kah (Author), Mary Sheena Maingeh (Author), Jonas Arnaud Kengne-Ouaffo (Author), Dizzle Bita Tayong (Author), Peter A Enyong (Author), Samuel Wanji (Author)
Format:	Book
Published:	Public Library of Science (PLoS), 2017-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
by: Samuel Wanji, et al.
Published: (2018)

Cross-Reactivity of Filariais ICT Cards in Areas of Contrasting Endemicity of Loa loa and Mansonella perstans in Cameroon: Implications for Shrinking of the Lymphatic Filariasis Map in the Central African Region.
by: Samuel Wanji, et al.
Published: (2015)

Evaluation of Lymphatic Filariasis and Onchocerciasis in Three Senegalese Districts Treated for Onchocerciasis with Ivermectin.
by: Nana O Wilson, et al.
Published: (2016)

Ivermectin treatment of Loa loa hyper-microfilaraemic baboons (Papio anubis): Assessment of microfilarial load reduction, haematological and biochemical parameters and histopathological changes following treatment.
by: Samuel Wanji, et al.
Published: (2017)

The Mbam drainage system and onchocerciasis transmission post ivermectin mass drug administration (MDA) campaign, Cameroon.
by: Raphael Awah Abong, et al.
Published: (2021)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: Winnen M., et al.
Published: (2002)

Can ivermectin mass treatments eliminate onchocerciasis in Africa?
by: M. Winnen, et al.

The impact of ivermectin on onchocerciasis in villages co-endemic for lymphatic filariasis in an area of onchocerciasis recrudescence in Burkina Faso.
by: Achille S Nikièma, et al.
Published: (2021)

Would ivermectin for malaria control be beneficial in onchocerciasis-endemic regions?
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2019)

Adherence to ivermectin is more associated with perceptions of community directed treatment with ivermectin organization than with onchocerciasis beliefs.
by: Fanny Nadia Dissak-Delon, et al.
Published: (2017)

On-going transmission of human onchocerciasis in the Massangam health district in the West Region of Cameroon: Better understanding transmission dynamics to inform changes in programmatic interventions.
by: Didier Bakajika, et al.
Published: (2018)

Parasitological, Hematological and Biochemical Characteristics of a Model of Hyper-microfilariaemic Loiasis (Loa loa) in the Baboon (Papio anubis).
by: Samuel Wanji, et al.
Published: (2015)

Uncertainty surrounding projections of the long-term impact of ivermectin treatment on human onchocerciasis.
by: Hugo C Turner, et al.
Published: (2013)

Interruption of infection transmission in the onchocerciasis focus of Ecuador leading to the cessation of ivermectin distribution.
by: Raquel Lovato, et al.
Published: (2014)

Impact of five annual rounds of mass drug administration with ivermectin on onchocerciasis in Sierra Leone
by: Joseph B. Koroma, et al.
Published: (2018)

Mansonella perstans microfilaremic individuals are characterized by enhanced type 2 helper T and regulatory T and B cell subsets and dampened systemic innate and adaptive immune responses.
by: Manuel Ritter, et al.
Published: (2018)

Reproductive status of Onchocerca volvulus after ivermectin treatment in an ivermectin-naïve and a frequently treated population from Cameroon.
by: Hugues C Nana-Djeunga, et al.
Published: (2014)

Assessment of the performance of community-directed treatment with ivermectin strategy for the control and elimination of onchocerciasis in Edo State, Nigeria
by: Amenze Oritsemofe Onowhakpor, et al.
Published: (2017)

The cost of annual versus biannual community-directed treatment of onchocerciasis with ivermectin: Ghana as a case study.
by: Hugo C Turner, et al.
Published: (2013)

Detecting and staging podoconiosis cases in North West Cameroon: positive predictive value of clinical screening of patients by community health workers and researchers
by: Samuel Wanji, et al.
Published: (2016)

Prevalence of epilepsy in the onchocerciasis endemic middle belt of Ghana after 27 years of mass drug administration with ivermectin
by: Kenneth Bentum Otabil, et al.
Published: (2023)

Impact of ivermectin and vector control on onchocerciasis transmission in Togo: Assessing the empirical evidence on trends in infection and entomological indicators.
by: Natalie V S Vinkeles Melchers, et al.
Published: (2024)

Feasibility of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: first evidence from studies in Mali and Senegal.
by: Lamine Diawara, et al.
Published: (2009)

Immunoepidemiological profiling of onchocerciasis patients reveals associations with microfilaria loads and ivermectin intake on both individual and community levels.
by: Kathrin Arndts, et al.
Published: (2014)

Mass Administration of Ivermectin for the Elimination of Onchocerciasis Significantly Reduced and Maintained Low the Prevalence of Strongyloides stercoralis in Esmeraldas, Ecuador.
by: Mariella Anselmi, et al.
Published: (2015)

Ivermectin as an adjuvant to anti-epileptic treatment in persons with onchocerciasis-associated epilepsy: A randomized proof-of-concept clinical trial.
by: Michel Mandro, et al.
Published: (2020)

Proof-of-principle of onchocerciasis elimination with ivermectin treatment in endemic foci in Africa: final results of a study in Mali and Senegal.
by: Mamadou O Traore, et al.
Published: (2012)

African Program for Onchocerciasis Control 1995-2010: Impact of Annual Ivermectin Mass Treatment on Off-Target Infectious Diseases.
by: Stanimira P Krotneva, et al.
Published: (2015)

Potential Value of Triple Drug Therapy with Ivermectin, Diethylcarbamazine, and Albendazole (IDA) to Accelerate Elimination of Lymphatic Filariasis and Onchocerciasis in Africa.
by: Peter U Fischer, et al.
Published: (2017)

Low prevalence of epilepsy and onchocerciasis after more than 20 years of ivermectin treatment in the Imo River Basin in Nigeria
by: Joseph N. F. Siewe, et al.
Published: (2019)

Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2023)

Epidemiology of onchocerciasis-associated epilepsy in the Mbam and Sanaga river valleys of Cameroon: impact of more than 13 years of ivermectin
by: Joseph Nelson Siewe Fodjo, et al.
Published: (2018)

A Knowledge, Attitudes and Practices Survey Conducted Three Years after Halting Ivermectin Mass Treatment for Onchocerciasis in Guatemala.
by: Frank O Richards, et al.
Published: (2016)

Triple-drug therapy with ivermectin, diethylcarbamazine and albendazole for the acceleration of lymphatic filariasis elimination in Kenya: Programmatic implementation and results of the first impact assessment.
by: Sammy M Njenga, et al.
Published: (2024)

Impact of short-term discontinuation of ivermectin-based chemoprevention on onchocerciasis transmission in endemic settings with long history of mass drug administration.
by: Arnauld Efon-Ekangouo, et al.
Published: (2023)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon.
by: Rogers Nditanchou, et al.
Published: (2024)

Correction: Ivermectin and doxycycline treatments against Onchocerciasis: Adaptations and impact among semi-nomadic population in Massangam Health District, Cameroon
Published: (2024)

A randomized, open-label study of the tolerability and efficacy of one or three daily doses of ivermectin plus diethylcarbamazine and albendazole (IDA) versus one dose of ivermectin plus albendazole (IA) for treatment of onchocerciasis.
by: Nicholas O Opoku, et al.
Published: (2023)

The effect of bi-annual community-directed treatment with ivermectin on the incidence of epilepsy in onchocerciasis endemic villages in South Sudan: a study protocol
by: Gasim Abd-Elfarag, et al.
Published: (2018)

Dynamics of Onchocerca volvulus microfilarial densities after ivermectin treatment in an ivermectin-naïve and a multiply treated population from Cameroon.
by: Sébastien D S Pion, et al.
Published: (2013)